Advertisement
Advertisement
U.S. Markets open in 2 hrs 43 mins
Advertisement
Advertisement
Advertisement
Advertisement

Qualigen Therapeutics, Inc. (QLGN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.0500+0.0500 (+5.00%)
At close: 03:59PM EST
1.0700 +0.02 (+1.90%)
Pre-Market: 06:16AM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.4340
52 Week Low 30.8800
50-Day Moving Average 31.1817
200-Day Moving Average 31.5786

Share Statistics

Avg Vol (3 month) 38.91M
Avg Vol (10 day) 3906.25k
Shares Outstanding 535.29M
Implied Shares Outstanding 6N/A
Float 825.67M
% Held by Insiders 18.72%
% Held by Institutions 113.67%
Shares Short (Dec 14, 2021) 41.8M
Short Ratio (Dec 14, 2021) 40.09
Short % of Float (Dec 14, 2021) 45.13%
Short % of Shares Outstanding (Dec 14, 2021) 45.10%
Shares Short (prior month Nov 14, 2021) 41.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 25, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3May 25, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin -216.48%
Operating Margin (ttm)-492.42%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.77M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)37.90%
Gross Profit (ttm)-2.68M
EBITDA -23.41M
Net Income Avi to Common (ttm)-10.33M
Diluted EPS (ttm)-0.3400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.32M
Total Cash Per Share (mrq)0.42
Total Debt (mrq)303.89k
Total Debt/Equity (mrq)2.80
Current Ratio (mrq)2.90
Book Value Per Share (mrq)0.37

Cash Flow Statement

Operating Cash Flow (ttm)-19.07M
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement